Impact of restricted amoxicillin/clavulanic acid use on Escherichia coli resistance-antibiotic DU90% profiles with bacterial resistance rates: A visual presentation

International Journal of Antimicrobial Agents

Volumn 36, Issue 4, 2010, Pages 369-373

  Mimica Matanovic, Suzana ^a   Bergman, Ulf ^b   Vukovic, Dubravka ^c   Wettermark, Björn ^b   Vlahovic Palcevski, Vera ^d  

^a University Hospital Center Osijek   (Croatia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Institute of Public Health for the Osijek Baranja County   (Croatia)

^d KBC RIJEKA   (Croatia)

Author keywords

Antibiotic policy; Antibiotic use; Hospital care; Quality assessment; Resistance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFALEXIN; CEFAZOLIN; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; MACROLIDE; MEROPENEM; METRONIDAZOLE; NETILMICIN; NORFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM; TUBERCULOSTATIC AGENT; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG USE; ESCHERICHIA COLI; HOSPITAL POLICY; MEDICAL INFORMATION; PHARMACEUTICAL CARE; PRIORITY JOURNAL;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CLAVULANIC ACID; CROATIA; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; ESCHERICHIA COLI; HEALTH POLICY; HOSPITALS, UNIVERSITY; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 77955925548     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.05.019     Document Type: Article

References (15)

1. Gould I.M. Antimicrobials: an endangered species?. Int J Antimicrob Agents 2007, 30:383-384.
2. Vlahovic-Palcevski V., Francetic I., Palcevski G., Novak S., Abram M., Bergman U. Antimicrobial use at a university hospital: appropriate or misused? A qualitative study. Int J Clin Pharmacol Ther 2007, 45:169-174.
3. Monnet D.L., López-Lozano J.M. Relationship between antibiotic consumption and resistance in European hospitals. Med Mal Infect 2005, 35(Suppl. 2):S127-S128.
4. Vlahovic-Palcevski V., Morovic M., Palcevski G. Antibiotic utilization at the university hospital after introducing an antibiotic policy. Eur J Clin Pharmacol 2000, 56:97-101.
5. Goryachkina K., Babak S., Burbello A., Wettemark B., Bergman U. Quality use of medicines: a new method of combining antibiotic consumption and sensitivity data-application in a Russian hospital. Pharmacoepidemiol Drug Saf 2008, 17:636-644.
6. Croatian Agency for Medicinal Products and Medical Devices. [accessed 24 October 2009]. http://www.almp.hr/%3Fln=hr%26w=publikacije%26d=promet_lijekova_2006.
7. Croatian Academy of Medical Sciences, Committee for Antibiotic Resistance Surveillance in Croatia. Antibiotic resistance in Croatia, 2006. Zagreb, Croatia: Croatian Academy of Medical Sciences; 2007.
8. WHO Collaborating Centre for Drug Statistics Methodology. Anatomic Therapeutic Chemical (ATC) Classification Index with Defined Daily Doses (DDDs). Oslo, Norway: WHO Collaborating Centre for Drug Statistics Methodology; 2005.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. Ninth informational supplement. Document M2-A9. Wayne, PA: CLSI; 2006.
10. Bergman U., Popa C., Tomson Y., Wettermark B., Einarson T.R., Åberg H., et al. Drug utilization 90%-a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 1998, 54:113-118.
11. Goossens H., Ferech M., Vander Stichele R., Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005, 365:579-587. ESAC Project Group.
12. Muller A., Monnet D.L., Talon D., Hénon, Bertrand X. Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital. Br J Clin Pharmacol 2006, 61:585-591.
13. Vlahović-Palcevski V., Morović M., Palcevski G., Betica-Radić L. Antimicrobial utilization and bacterial resistance at three different hospitals. Eur J Epidemiol 2001, 17:375-383.
14. Leflon-Guibout V., Ternat G., Heym B., Nicolas-Chanoine M.H. Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection. J Antimicrob Chemother 2002, 49:367-371.
15. Kahlmeter G An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 2003, 51:69-76. ECO.SENS.